Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EUSA Pharma

www.eusapharma.com

Latest From EUSA Pharma

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology firms at the J.P. Morgan meeting.

Deals Business Strategies

EUSA Sylvant Licence Marks Toehold Into US Rare Disease Market

Six months after selling its critical care business to refocus on rare diseases and oncology, EUSA Pharma has made its first move into those markets by licensing a Janssen product for a rare blood disorder.

Rare Diseases Deals

Bring Them On: 40 Orphan, Cancer Drugs Set For Priority Review In China

New treatments for spinal muscular atrophy, glioblastoma, Gaucher's disease and others could be soon be hitting the China market following the awarding of priority reviews to a large list of novel therapies.

China Rare Diseases

Asia Deal Watch: FujiFilm, Hisun Team To Develop Flu Drug For Chinese Market

Agreement between FujiFilm and Hisun sets plan for developing the novel flu drug Avigan in China. Also, CANbridge and WuXi partner in rare diseases, and Kissei gets Asian rights to Rigel’s Tavalisse.

Asia Pacific Deals
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Dental & Oral Products
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Poison (Antidote)
  • Alias(es)
  • Essex Bidco Ltd.
  • EUSA Pharma Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • EUSA Pharma
  • Senior Management
  • Lee Morley, CEO
    Emma Johnson, CFO
    Jonathan Morgan, Med. Dir.
    Ben Owens, Head, Bus. Dev.
  • Contact Info
  • EUSA Pharma
    Phone: 3305001140
    Breakspear Park, Breakspear Way, Gr. Fl.
    Ste. GE
    Hemel Hempstead, PA HP2 4TZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register